Intrathecal corticosteroids might slow Alzheimer’s disease progression
Joseph Martin Alisky1,21Marshfield Clinic Research Foundation; 2Marshfield Clinic-Thorp Center, Marshfield, Wisconsin, USAAbstract: Anti-inflammatory drugs for treatment and prevention of Alzheimer’s disease have to date proved disappointing, including a large study of low-dose prednis...
Guardado en:
Autor principal: | Joseph Martin Alisky |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a7bb9ad46b8e43bebd7a081728de5468 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
An update on the toxicity of Aβ in Alzheimer’s disease
por: Jürgen Götz, et al.
Publicado: (2008) -
Update on the use of memantine in Alzheimer’s disease
por: Robert J van Marum
Publicado: (2009) -
Ceruloplasmin and iron in Alzheimer’s disease and Parkinson’s disease: a synopsis of recent studies
por: Kristinsson J, et al.
Publicado: (2012) -
Brain amyloid β protein and memory disruption in Alzheimer’s disease
por: Weiming Xia
Publicado: (2010) -
Present and prospective clinical therapeutic regimens for Alzheimer’s disease
por: Mustafa M Husain, et al.
Publicado: (2008)